LATEST RELEASES FROM GPM
A bold initiative to prove that stabilizing treatment for Spinal Muscular Atrophy (SMA) exists, pan-European access does not.
We visualised and centralised data in 12 key performance rankings, across 24 countries, using 78 data comparisons to illustrate that 18 european countries fail to provide available life-changing medicine without restrictions.
OdySMA phase 1 - ‘the Evidence’ - is now online, featuring country-by-country assessments, a data-set specific comparison engine, healthcare & financial data mapping visualizations and the 'Nations League' - a country performance system, compiled from results across the key indicators. Watch out for phase II - 'Humanizaing the data'.